Prevalence of Treatment‐Resistant Schizophrenia: A Nationwide Multicenter Study
The prevalence of treatment‐resistant schizophrenia (TRS) among patients with schizophrenia remains insufficiently characterized using nationwide data and standardized diagnostic criteria.